欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
LV/H/0222/001
药品名称
Ipidacrine Grindeks 20 mg tablets
活性成分
ipidacrine hydrochloride 20.0 mg
剂型
Tablet
上市许可持有人
Grindeks AS Krustpils Iela 53, Riga 1057, Latvia
参考成员国 - 产品名称
Latvia (LV)
互认成员国 - 产品名称
Slovakia (SK)
Slovenia (SI)
Croatia (HR)
Poland (PL)
Lithuania (LT)
-
Hungary (HU)
Bulgaria (BG)
Ipigrix
Romania (RO)
许可日期
2022/05/29
最近更新日期
2022/05/30
药物ATC编码
N07AA Anticholinesterases
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final PL
|
LV_H_0222_001_DC_Ipidacrine tabl_PIL_FINAL
Date of last change:2024/09/06
Final SPC
|
LV_H_0222_001_DC_Ipidacrine tabl_SmPC_FINAL
Date of last change:2024/09/06
Final Labelling
|
LV_H_0222_001_DC_LAB_FINAL_CLEAN
Date of last change:2024/09/06
PubAR
|
LV_H_0222_001_DC_PAR
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase